The Stanford Center for Neuroscience in Women’s Health (SCNWH) is dedicated to the mission of establishing comprehensive standard of care for women’s mental health services. Our goal is to provide innovative, state of the art treatment in the field of women’s mental health through the integration of biomedical research, clinical practice, and clinical education. The study of women has been historically neglected in biomedical research, resulting in a gaping lack of information about how reproductive hormones affect the human brain in health and disease.  In particular, we need to learn more about how mental health interacts with gender and reproductive hormones during a woman’s lifespan.   Under the leadership and expertise of Stanford researchers and clinicians, the Center aims to forge new, scientifically-based strategies to address the full spectrum of women’s mental health issues, while dramatically expanding the boundaries of our knowledge about the interplay between gender and brain function. 

• October 2019
• We are now actively recruiting for our postpartum depression study. For more information on the study, check out the Research tab (located on the left side of the website), or contact Lexi Nutkiewicz at lexinut7@stanford.edu or call 650-724-4559.
• August 2019
• Dr. Rasgon presented at the WPA World Congress of Psychiatry in Lisbon, Portugal. Her talk was titled "Novel mechanisms of brain plasticity for personalized interventions in neuropsychiatric disorders."
• June 2019
• Dr. Rasgon presented Grand Rounds at the University of Alabama, Birmingham. Her talk was entitled "Epigenetic and Genetic Correlates of the Metabolic Subtype of Depression."
• May 2019
• Enrollment for the study on the role of insulin resistance in accelerated cognitive aging officially ended.
• January 2019
• Our recently published article on Mifepristone was featured on Science Trends' website. Check it out here: https://sciencetrends.com/how-does-stress-impact-mood-disorders/
• July 2018
• Our research on the cognitive effects of Mifepristone in overweight, euthymic adults with depressive disorders was published in the Journal of Affective Disorders.
• April 2018:
• Dr. Rasgon will be giving both Psychiatry and Medical Grand Rounds at the Louisiana State University this April. Her talks will focus on "Diagnosis and Treatment of Mood Disorders in Women of Reproductive Age."
• January 2018:
• Dr. Rasgon presented the Psychiatry Grand Rounds here at Stanford on January 25. Her talked was entitled "Biomarkers of Allostatic Load in Mood Disorders." 
• December 2017:
• Dr. Rasgon attended the annual American College for Neuropsychopharmacology conference in Palm Springs, CA to chair a mini panel entitled "Genetic, Epigenetic and Neural Correlates of Allostatic Load in Neuropsychiatry."
• July 2017: 
• Dr. Ballon is currently co-authoring a book on Early Psychosis for the APA. Check back soon for more details.
• June 2017:
• Check out the Psychopathology and Allostatic load across the Life Span (PALS) collaborative network, co-founded by our very own Dr. Rasgon! 
• May 2017:
• We have concluded data collection for the study on stress and longevity in executives. Stay tuned for the publication!
• February 2017:
• We are now actively recruiting for our study on insulin resistance and accelerated cognitive aging. For more information on the study, check out our page on ClinicalTrials.gov (link located in sidebar to the right), or contact Alison Myoraku at myoraku@stanford.edu or (650) 736 -2182.
• October 2016: 
• We are launching a study on the role of insulin resistance in accelerated cognitive aging. Please contact our study coordinator, Alison Myoraku, at myoraku@stanford.edu for more information.